Contemporary Breast Radiotherapy and Cardiac Toxicity

Seminars in Radiation Oncology

Volumn 26, Issue 1, 2016, Pages 71-78

  Yeboa, Debra Nana ^a   Evans, Suzanne Buckley ^a  

^a YALE NEW HAVEN HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; CALCIUM;

ACCELERATED PARTIAL BREAST IRRADIATION; ARTERY INTIMA PROLIFERATION; BODY POSTURE; BRACHYTHERAPY; BREAST CANCER; BREAST FIBROSIS; BREAST RADIOTHERAPY; CANCER CONTROL; CANCER RADIOTHERAPY; CANCER SURVIVAL; CARDIOTOXICITY; COMPUTER ASSISTED RADIOTHERAPY; COMPUTER ASSISTED TOMOGRAPHY; CORONARY ARTERY CALCIUM SCORE; CYTOKINE PRODUCTION; DEEP INSPIRATION BREATH HOLD; DISEASE FREE SURVIVAL; DOSIMETRY; EXTERNAL BEAM RADIOTHERAPY; HUMAN; INTENSITY MODULATED RADIATION THERAPY; LINEAR ACCELERATOR; OUTCOME ASSESSMENT; OVERALL SURVIVAL; OXIDATIVE STRESS; PARTIAL BODY RADIATION; PATHOPHYSIOLOGY; PATIENT MONITORING; PATIENT POSITIONING; PRIORITY JOURNAL; PROTON THERAPY; RADIATION DOSE DISTRIBUTION; RADIATION DOSE FRACTIONATION; RADIATION FIELD; RADIATION RESPONSE; RADIATION SHIELD; RADIOLOGICAL PROCEDURES; REVIEW; RISK BENEFIT ANALYSIS; RISK REDUCTION; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SURVIVAL TIME; ADJUVANT RADIOTHERAPY; BREAST NEOPLASMS; FEMALE; RADIATION INJURIES; RADIOTHERAPY DOSAGE; RADIOTHERAPY PLANNING SYSTEM;

BREAST NEOPLASMS; CARDIOTOXICITY; FEMALE; HUMANS; RADIATION INJURIES; RADIOTHERAPY DOSAGE; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; RADIOTHERAPY, ADJUVANT; RADIOTHERAPY, INTENSITY-MODULATED;

EID: 84961825279     PISSN: 10534296     EISSN: 15329461     Source Type: Journal    
DOI: 10.1016/j.semradonc.2015.09.003     Document Type: Review

References (61)

1. Darby S.C., Ewertz M., McGale P., et al. Risk of ischemic heart disease in women after radiotherapy for breast cancer. N Engl J Med 2013, 368:987-998.
2. Haubner F., Ohmann E., Pohl F., et al. Effects of radiation on the expression of adhesion molecules and cytokines in a static model of human dermal microvascular endothelial cells. Clin Hemorheol Microcirc 2013, 54:371-379.
3. Maity A., Kao G.D., Muschel R.J., et al. Potential molecular targets for manipulating the radiation response. Int J Radiat Oncol Biol Phys 1997, 37:639-653.
4. Darby S.C., Cutter D.J., Boerma M., et al. Radiation-related heart disease: Current knowledge and future prospects. Int J Radiat Oncol Biol Phys 2010, 76:656-665.
5. Taunk N.K., Haffty B.G., Kostis J.B., et al. Radiation-induced heart disease: Pathologic abnormalities and putative mechanisms. Front Oncol 2015, 5:39.
6. Slater J.M. From x-rays to ion beams: A short history of radiation therapy. Ion Beam Therapy, Biological and Medical Physics, Biomedical Engineering 2012, 3-16. Springer-Verlag, Berlin, Heidelberg. U. Linz (Ed.).
7. Goodman L.R. The Beatles, the Nobel Prize, and CT scanning of the chest. Radiol Clin North Am 2010, 48:1-7.
8. Dawson L.A., Jaffray D.A. Advances in image-guided radiation therapy. J Clin Oncol 2007, 25:938-946.
9. Overgaard M., Hansen P.S., Overgaard J., et al. Postoperative radiotherapy in high-risk premenopausal women with breast cancer who receive adjuvant chemotherapy. Danish Breast Cancer Cooperative Group 82b Trial. N Engl J Med 1997, 337:949-955.
10. Overgaard M., Jensen M.B., Overgaard J., et al. Postoperative radiotherapy in high-risk postmenopausal breast-cancer patients given adjuvant tamoxifen: Danish Breast Cancer Cooperative Group DBCG 82c randomised trial. Lancet 1999, 353:1641-1648.
11. Katz A., Strom E.A., Buchholz T.A., et al. The influence of pathologic tumor characteristics on locoregional recurrence rates following mastectomy. Int J Radiat Oncol Biol Phys 2001, 50:735-742.
12. Prosnitz R.G., Marks L.B. Radiation-induced heart disease: vigilance is still required. J Clin Oncol 2005, 23:7391-7394.
13. Pezner R.D., Lipsett J.A., Forell B., et al. The reverse hockey stick technique: postmastectomy radiation therapy for breast cancer patients with locally advanced tumor presentation or extensive loco-regional recurrence. Int J Radiat Oncol Biol Phys 1989, 17:191-197.
14. Pierce L.J., Butler J.B., Martel M.K., et al. Postmastectomy radiotherapy of the chest wall: Dosimetric comparison of common techniques. Int J Radiat Oncol Biol Phys 2002, 52:1220-1230.
15. Yeboa D.N., Aneja S., Montana G., et al. Historical trends in radiotherapy use in prevalent malignancies over 38 years in SEER. J Radiat Oncol 2015, 4:11-17.
16. Early Breast Cancer Trialists' Collaborative Group Favourable and unfavourable effects on long-term survival of radiotherapy for early breast cancer: An overview of the randomised trials. Lancet 2000, 355:1757-1770.
17. Raj K.A., Evans E.S., Prosnitz R.G., et al. Is there an increased risk of local recurrence under the heart block in patients with left-sided breast cancer?. Cancer J 2006, 12:309-317.
18. Canney P.A., Deehan C., Glegg M., et al. Reducing cardiac dose in post-operative irradiation of breast cancer patients: The relative importance of patient positioning and CT scan planning. Br J Radiol 1999, 72:986-993.
19. Canney P.A., Sanderson R., Deehan C., et al. Variation in the probability of cardiac complications with radiation technique in early breast cancer. Br J Radiol 2001, 74:262-265.
20. Formenti S.C., DeWyngaert J.K., Jozsef G., et al. Prone vs supine positioning for breast cancer radiotherapy. J Am Med Assoc 2012, 308:861-863.
21. Griem K.L., Fetherston P., Kuznetsova M., et al. Three-dimensional photon dosimetry: A comparison of treatment of the intact breast in the supine and prone position. Int J Radiat Oncol Biol Phys 2003, 57:891-899.
22. Lu H.M., Cash E., Chen M.H., et al. Reduction of cardiac volume in left-breast treatment fields by respiratory maneuvers: A CT study. Int J Radiat Oncol Biol Phys 2000, 47:895-904.
23. Korreman S.S., Pedersen A.N., Nottrup T.J., et al. Breathing adapted radiotherapy for breast cancer: Comparison of free breathing gating with the breath-hold technique. Radiother Oncol 2005, 76:311-318.
24. Remouchamps V.M., Vicini F.A., Sharpe M.B., et al. Significant reductions in heart and lung doses using deep inspiration breath hold with active breathing control and intensity-modulated radiation therapy for patients treated with locoregional breast irradiation. Int J Radiat Oncol Biol Phys 2003, 55:392-406.
25. Mast M.E., van Kempen-Harteveld L., Heijenbrok M.W., et al. Left-sided breast cancer radiotherapy with and without breath-hold: Does IMRT reduce the cardiac dose even further?. Radiother Oncol 2013, 108:248-253.
26. Smith B.D., Arthur D.W., Buchholz T.A., et al. Accelerated partial breast irradiation consensus statement from the American Society for Radiation Oncology (ASTRO). Int J Radiat Oncol Biol Phys 2009, 74:987-1001.
27. Hiatt J.R., Evans S.B., Price L.L., et al. Dose-modeling study to compare external beam techniques from protocol NSABP B-39/RTOG 0413 for patients with highly unfavorable cardiac anatomy. Int J Radiat Oncol Biol Phys 2006, 65:1368-1374.
28. Formenti S.C., Hsu H., Fenton-Kerimian M., et al. Prone accelerated partial breast irradiation after breast-conserving surgery: Five-year results of 100 patients. Int J Radiat Oncol Biol Phys 2012, 84:606-611.
29. Whelan T.J., Pignol J.P., Levine M.N., et al. Long-term results of hypofractionated radiation therapy for breast cancer. N Engl J Med 2010, 362:513-520.
30. Paszat L.F., Mackillop W.J., Groome P.A., et al. Mortality from myocardial infarction following postlumpectomy radiotherapy for breast cancer: A population-based study in Ontario, Canada. Int J Radiat Oncol Biol Phys 1999, 43:755-762.
31. Marhin W., Wai E., Tyldesley S. Impact of fraction size on cardiac mortality in women treated with tangential radiotherapy for localized breast cancer. Int J Radiat Oncol Biol Phys 2007, 69:483-489.
32. Appelt A.L., Vogelius I.R., Bentzen S.M. Modern hypofractionation schedules for tangential whole breast irradiation decrease the fraction size-corrected dose to the heart. Clin Oncol (R Coll Radiol) 2013, 25:147-152.
33. Lin L.L., Vennarini S., Dimofte A., et al. Proton beam versus photon beam dose to the heart and left anterior descending artery for left-sided breast cancer. Acta Oncol 2015, 1-8.
34. Cuaron J.J., Chon B., Tsai H., et al. Early toxicity in patients treated with postoperative proton therapy for locally advanced breast cancer. Int J Radiat Oncol Biol Phys 2015, 92:284-291.
35. Patt D.A., Goodwin J.S., Kuo Y.F., et al. Cardiac morbidity of adjuvant radiotherapy for breast cancer. J Clin Oncol 2005, 23:7475-7482.
36. Giordano S.H., Kuo Y.F., Freeman J.L., et al. Risk of cardiac death after adjuvant radiotherapy for breast cancer. J Natl Cancer Inst 2005, 97:419-424.
37. Rutter C.E., Chagpar A.B., Evans S.B. Breast cancer laterality does not influence survival in a large modern cohort: Implications for radiation-related cardiac mortality. Int J Radiat Oncol Biol Phys 2014, 90:329-334.
38. Early Breast Cancer Trialists' Collaborative Group (EBCTCG), Darby S., McGale P., et al. Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: Meta-analysis of individual patient data for 10,801 women in 17 randomised trials. Lancet 2011, 378:1707-1716.
39. Evans S.B., Sioshansi S., Moran M.S., et al. Prevalence of poor cardiac anatomy in carcinoma of the breast treated with whole-breast radiotherapy: Reconciling modern cardiac dosimetry with cardiac mortality data. Am J Clin Oncol 2012, 35:587-592.
40. Demirci S., Nam J., Hubbs J.L., et al. Radiation-induced cardiac toxicity after therapy for breast cancer: Interaction between treatment era and follow-up duration. Int J Radiat Oncol Biol Phys 2009, 73:980-987.
41. Cuzick J., Stewart H., Rutqvist L., et al. Cause-specific mortality in long-term survivors of breast cancer who participated in trials of radiotherapy. J Clin Oncol 1994, 12:447-453.
42. Shimizu Y., Kodama K., Nishi N., et al. Radiation exposure and circulatory disease risk: Hiroshima and Nagasaki atomic bomb survivor data, 1950-2003. Br Med J 2010, 340:b5349.
43. Evans S.B., Panigrahi B., Northrup V., et al. Analysis of coronary artery dosimetry in the 3-dimensional era: Implications for organ-at-risk segmentation and dose tolerances in left-sided tangential breast radiation. Pract Radiat Oncol 2013, 3:e55-e60.
44. Correa C.R., Litt H.I., Hwang W.T., et al. Coronary artery findings after left-sided compared with right-sided radiation treatment for early-stage breast cancer. J Clin Oncol 2007, 25:3031-3037.
45. Tjessem K.H., Bosse G., Fossa K., et al. Coronary calcium score in 12-year breast cancer survivors after adjuvant radiotherapy with low to moderate heart exposure-Relationship to cardiac radiation dose and cardiovascular risk factors. Radiother Oncol 2015, 114:328-334.
46. Gyenes G., Fornander T., Carlens P., et al. Myocardial damage in breast cancer patients treated with adjuvant radiotherapy: a prospective study. Int J Radiat Oncol Biol Phys 1996, 36:899-905.
47. Prosnitz R.G., Hubbs J.L., Evans E.S., et al. Prospective assessment of radiotherapy-associated cardiac toxicity in breast cancer patients: Analysis of data 3 to 6 years after treatment. Cancer 2007, 110:1840-1850.
48. Hardenbergh P.H., Munley M.T., Bentel G.C., et al. Cardiac perfusion changes in patients treated for breast cancer with radiation therapy and doxorubicin: Preliminary results. Int J Radiat Oncol Biol Phys 2001, 49:1023-1028.
49. Recht A. Which breast cancer patients should really worry about radiation-induced heart disease-And how much?. J Clin Oncol 2006, 24:4059-4061.
50. Doyle J.J., Neugut A.I., Jacobson J.S., et al. Chemotherapy and cardiotoxicity in older breast cancer patients: A population-based study. J Clin Oncol 2005, 23:8597-8605.
51. Guo S., Wong S. Cardiovascular toxicities from systemic breast cancer therapy. Front Oncol 2014, 4:346.
52. Villarraga H.R., Herrmann J., Nkomo V.T. Cardio-oncology: Role of echocardiography. Prog Cardiovasc Dis 2014, 57:10-18.
53. Fedele C., Riccio G., Malara A.E., et al. Mechanisms of cardiotoxicity associated with ErbB2 inhibitors. Breast Cancer Res Treat 2012, 134:595-602.
54. Gandhi S., Verma S. Aromatase inhibitors and cardiac toxicity: Getting to the heart of the matter. Breast Cancer Res Treat 2007, 106:1-9.
55. Gyenes G., Gagliardi G., Lax I., et al. Evaluation of irradiated heart volumes in stage I breast cancer patients treated with postoperative adjuvant radiotherapy. J Clin Oncol 1997, 15:1348-1353.
56. Freedman G.M., Fowble B.L., Nicolaou N., et al. Should internal mammary lymph nodes in breast cancer be a target for the radiation oncologist?. Int J Radiat Oncol Biol Phys 2000, 46:805-814.
57. Matzinger O., Heimsoth I., Poortmans P., et al. Toxicity at three years with and without irradiation of the internal mammary and medial supraclavicular lymph node chain in stage I to III breast cancer (EORTC trial 22922/10925). Acta Oncol 2010, 49:24-34.
58. Xu N., Ho M.W., Li Z., et al. Can proton therapy improve the therapeutic ratio in breast cancer patients at risk for nodal disease?. Am J Clin Oncol 2014, 37:568-574.
59. Chen T., Reyhan M., Yue N., et al. Tagged MRI based cardiac motion modeling and toxicity evaluation in breast cancer radiotherapy. Front Oncol 2015, 5:9.
60. Tian S., Hirshfield K.M., Jabbour S.K., et al. Serum biomarkers for the detection of cardiac toxicity after chemotherapy and radiation therapy in breast cancer patients. Front Oncol 2014, 4:277.
61. Sharp TE, 3rd, George JC: Stem cell therapy and breast cancer treatment: Review of stem cell research and potential therapeutic impact against cardiotoxicities due to breast cancer treatment. Front Oncol 4:299, 2014.